Formaldehyde in dentistry: A review for the millennium

Journal of Clinical Pediatric Dentistry

Volumn 22, Issue 2, 1998, Pages 167-177

  Lewis, Bradley ^a,b,c,d  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; BIOMEDICAL AND DENTAL MATERIALS; CARCINOGEN; FORMALDEHYDE; FORMOCRESOL; MUTAGENIC AGENT;

ANIMAL; DRUG SCREENING; ENDODONTICS; HUMAN; REVIEW;

ALDEHYDES; ANIMALS; CARCINOGENS; DENTAL MATERIALS; DRUG EVALUATION; FORMALDEHYDE; FORMOCRESOLS; HUMANS; MUTAGENS; PULPOTOMY; ROOT CANAL IRRIGANTS;

EID: 0032325079     PISSN: 10534628     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Lewis BB. Formaldehyde in dentistry: a review of mutagenic and carcinogenic potential. JADA 103(3): 429-34, 1981.
2. Lewis BB. Formaldehyde in dentistry. JADA 124: 16, 1993
3. Gergerly JM, Difiore PM. Intracanal mediation in endodontic treatment: a survery of endodontic programs, Gen Dent 41: 328-31, 1993.
4. Judd PL, Kenny DJ. Non-aldehyde pulpectomy technique for primary teeth. Ont Dent 122: 83-85, 1991.
5. Feigal, RJ, Messer HH. A critical look at glutaraldehyde. Pediatric Dentistry 12: 69-71, 1990.
6. Yacobi R, Kenny DJ, Judd PL, Johnston, DH. Evolving primary pulp therapy techniques. JADA 122: 83-85, 1991.
7. Kenny, DJ Formocresol concerns, a review. J Canad Dent Assn 5, 401-404, 1987.
8. Orstavik D, Hongslo JK. Mutagenicity of endodontic sealers. Biomaterials 6: 129-132, 1985.
9. Orr DL. Parasthesia of the trigeminal nerve secondary to endodontic manipulation with N2. Headache 25: 334-336, 1985.
10. Pashley EL. Systemic distribution of 14C-formaldehyde from formocresol-treated pulpotomy sites. J Dent Res 59: 602-607, 1980.
11. Ranly DM. Assessment fo the systremic distribution and toxicity of formaldehyde following pulpotomy treatemnt: part one. J Dent Child 52: 431-434, 1986.
12. Myers DR. The acute toxicity of high doses of systemically administered formocresol in dogs. Pediat Dent 3: 37-41, 1981.
13. Peck AH. The essential oils and some other agents, their antiseptic value, also their irritating properties. Dent Reve 11: 593-608, 1898.
14. Black GV. Special dental pathology, ed 2. Chicago, Medico-Dental Publishing Co, p 296, 1920.
15. Brown BD. Studies of Sargenti technique of endodontics-reaction to the materials. J Endod 4: 238, 1978.
16. Myers DR. Distribution of 14C-formaldehyde after pulpotomy with formocesol, JADA 96: 805-812, 1978.
17. Block RM. Cell-mediated immune response to dog pulp tissue altered by 6.5% paraformaldehyde via the root canal. J Endod 4: 24-429, 1977.
18. Seow WK, Thong YH. Evaluation of the novel anti-inflammatory agent tetrandrine as a pulpotomy medicament in a canine model. Pediatr Dent 15: 260-6, 1993.
19. Lu DP, Hersh EV. Intra-canal dissolution of Sargenti paste. N Y State Dent J 60: 43-8, 1994.
20. Rigby JJ. Sargenti defended [letter; comment]. J Am Dent Assoc 125: 498, 500, 1994.
21. Chase WR, Dietz G Sr. Two sides of the Sargenti question. J Mich Dent Assoc 75: 36-8, 40-1, 1994.
22. Sayed F, Seite-Bellezza D, Sans B, Bayle-Lebey P, Marguery MC, Bazex J. Contact urticaria from formaldehyde in a root-canal dental paste. Contact Dermatitis 33: 353, 1995.
23. Griesemer RA, Ulsamer AG, Arcos JC, Beall JR, Blair AE, Collins TF, De Serres FJ, Everson RB, Gamble JF, Gaylor DW, Groth DH, Kang HK, Keenlyside RA, Lloyd JW, Nettesheim P, Saffiotti U, Weisburger EK. Report of the federal panel on formaldehyde. Environ Health Perspect 43: 139-168, 1982.
24. Connors TA. Carcinogenicity of medicines ACS Monogr 182: 1241, 1984.
25. Ashford NA, Ryan CW, Caldart CC. Law and science policy in federal regulation of formaldehyde. Science 222: 894-900, 1983.
26. Bos RP, Hulshof CT, Theuws JL, Henderson PT. Genotoxic exposure of workers creosoting wood. Br J Ind Med 41: 260-2, 1984.
27. Nelson N, Levine RJ, Albert RE, Blair AE, Griesemer RA, Landrigan PJ, Stayner LT, Swenberg JA. Contribution of formaldehyde to respiratory cancer. Environ Health Perspect 70: 23-35, 1986.
28. Frye B, Parker T. Formaldehyde: a candidate toxic air contaminant. final report Available from National Technical Information Service, Springfield, VA, as NTIS/PB88-186655, 14 p. 1988.
29. Heck HD. Toxicologic implications of formaldehyde formation in vivo from industrial chemicals and pharmaceuticals. CIIT Act 9: 1-5, 1989.
30. Casanova M, Heck H. The impact of DNA-protein cross-linking studies on quantitative risk assessments of formaldehyde. CIIT Act 11: 1-6, 1991.
31. Kerns WD, Pavkov KL Donofrio DJ Gralla EJ Swenberg JA Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res 43: 4382-92, 1983.
32. Connor TH. Detection of chemical mutagens in the urine of humans: studies of exposure to formaldehyde and cigarette smoke. Diss Abstr Int (Sci) 43: 667-8, 1982.
33. Neal RA, Gibson JE. The uses of toxicology and epidemiology in identifying and assessing carcinogenic risks. Occup Saf Health 9: 39-65, 1984.
34. World Health Organization. Formaldehyde. Environ Health Criteria 89: 1-219, 1989.
35. Kolar GF, Schendzielorz M. Reactions of substituted arenediazonium chlorides with methylamine- formaldehyde premix revisited: reactivity and transformations of methylolamine intermediates and their biological significance. Z Naturforsch 42: 41-6, 1987.
36. Blackwell M, Kang H, Thomas A, Infante P. Formaldehyde: evidence of carcinogenicity. Am Ind Hyg Assoc J 42(7): A-34, A-36, A-38 ,A-40, A-42, A-44, A-46. 1981.
37. Pabst R. Exposure to formaldehyde in anatomy: an occupational health hazard? Anal Rec 219: 109-12, 1987.
38. Cohn MS. Description of a carcinogenic risk assessment used in a regulatory proceeding: formaldehyde. Banbury Rep 19: 269-77, 1985.
39. Orstavik D, Hongslo JK. Mutagenicity of endodontic sealers. Biomaterials 6: 129-32, 1985.
40. Wiberg GS, Baranowski E. Health implications of ureaformaldehyde foam insulation. Can J Public Health 72: 335-338, 1981.
41. Pool BL, Frei E, Plesch WJ, Romruen K, Wiessler M. Formaldehyde as a possible mutagenic metabolite of N-nitrodimethylamine and of other agents which are suggested to yield non-alkylating species in vitro. Carcinogenesis 5: 809-14, 1984.
42. Pool BL, Wiessler M. Investigations on the mutagenicity of primary and secondary alpha- acetoxynitrosamines with Salmonella typhimurium: activation and deactivation of structurally related compounds by S-9. Carcinogenesis 2: 991-7, 1981.
43. Casanova M, Heck H. The impact of DNA-protein cross-linking studies on quantitative risk assessments of formaldehyde. CIIT Act 11: 1-6, 1991.
44. LiY, Noblitt TW, Dunipace AJ, Stookey GK. Evaluation of mutagenicity of restorative dental materials using the Ames Salmonella/microsome test. J Dent Res 69: 1188-92, 1990.
45. Shaham J Bomstein Y Meltzer A Kaufman Z Palma E Ribak J DNA - protein crosslinks, a biomarker of exposure to formaldehyde - in vitro and in vivo studies. Carcinogenesis 17: 121-5, 1996.
46. Wonisch W, Schaur RJ, Bilinski T, Esterbauer H. Assessment of growth inhibition by aldehydic lipid peroxidation products and related aldehydes by Saccharomyces cerevisiae. Cell Biochem Funct 13: 91-8, 1995.
47. Grafstrom RC, Hsu IC, Harris CC. Mutagenicity of formaldehyde in Chinese hamster lung fibroblasts: synergy with ionizing radiation and N-nitroso-N-methylurea. Chem Biol Interact 86: 41-9, 1993.
48. Marselos M, Vasiliou V. Effect of various chemicals on the aldehyde dehydrogenase activity of the rat liver cytosol. Chem Biol Interact 79: 79-89, 1991.
49. Yue L, Wang M, Zhou Z. Usage of the geno-toxicological studies in the biological evaluation of dental materials. Chung Hua Kou Chiang Hsueh Tsa Chih 30: 6-9, 63, 1995.
50. Beauchamp RO Jr, St. Clair MB, Fennell TR, Clarke DO, Morgan KT, St Clair MB. A critical review of the toxicology of glutaraldehyde. Crit Rev Toxicol 22: 143-74, 1992.
51. Waterhouse PJ. Formocresol and alternative primary molar pulpotomy medicaments: a review. Endod Dent Traumatol 11: 157-62, 1995.
52. Feron VJ, Til HP, de Vrijer F, Woutersen RA, Cassee FR, van Bladeren PJ. Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat Res 259: 363-85, 1991.
53. Zimmermann FK, Mohr A. Formaldehyde, glyoxal, urethane, methyl carbamate, 2,3-butanedione, 2,3-hexanedione, ethyl acrylate, bromoacetonitrile and 2- hydroxypropionitrile induce chromosome loss in Saccharomyces cerevisiae. Mutat Res 270: 151-66, 1992.
54. Conaway CC, Whysner J, Verna LK, Williams GM. Formaldehyde mechanistic data and risk assessment: endogenous protection from DNA adduct formation. Pharmacol Ther 71: 29-55, 1996.
55. Krogulski A. [Usefulness of the fruit fly for assessment of mutagenicity of benzene, acetaldehyde and formaldehyde] Przydatnosc muszki owocowej do oceny aktywnosci mutagennej benzenu oraz aldehydow octowego imrowkowego. Rocz Panstw Zakl Hig 45: 151-5, 1994.
56. Fishbein. Exposure from occupational versus other sources. Scand J Work Environ Health 18 Suppl 1:5-16, 1992.
57. Feron VJ, Groten JP, Jonker D, Cassee FR, van Bladeren PJ. Toxicology of chemical mixtures: challenges for today and the future. Toxicology 105: 415-27, 1995.
58. Trent MB, Lyles GA, Tao M, Ansari GA. Methylamine metabolism to formaldehyde by vascular semicarbazide- sensitive amine oxidase. Toxicology 73: 251-8, 1992.
59. Lewis BB. Formaldehyde in dentistry [letterl. J Am Dent Assoc 124: 14, 16, 1993.
60. Nunn JH Smeaton I Gilroy J. The development of formocresol as a medicament for primary molar pulpotomy procedures. J Dent Child 63: 51-3, 1996.
61. Waterhouse PJ. Formocresol and alternative primary molar pulpotomy medicaments: a review. Endod Dent Traumatol 11: 157-62, 1995.
62. Wolff GK. Glutaraldehyde: an alternativeto formocresol? Gen Dent 42: 260-3, 1994.
63. Yamasaki M, Nakamura H, Kameyama Y. Irritating effect of formocresol after pulpectomy in vivo. Int Endod J 27: 245-51, 1994.
64. Roberts JF. Treatment of vital and non-vital primary molar teeth by one-stage formocresol pulpotomy: clinical success and effect upon age at exfoliation. Int J Paediatr Dent 6: 25, 1996.
65. Oztas N, Ulusu T, Oygur T, Cokpekin F. Comparison of electro-surgery and formocresol as pulpotomy techniques in dog primary teeth. J Clin Pediatr Dent 18: 285-9, 1994.
66. Ohara P, Torabinejad M, Kettering JD. Antibacterial effects of various endodontic medicaments on selected anaerobic bacteria. J Endod 19: 498-500, 1993.
67. Breault LG, Schuster GS, Billman MA, Hanson BS 3rd, Kudryk VL, Pashley DH, Runner RR, McPherson JC 3rd. The effects of intracanal medicaments, fillers, and sealers on the attachment of human gingival fibroblasts to an exposed dentin surface free of a smear layer. J Periodontol 66: 545-51, 1995.
68. Shapiro S, Meier A, Guggenheim B. The antimicrobial activity of essential oils and essential oil components towards oral bacteria. Oral Microbiol Immunol 9: 202-8, 1994.
69. Tchaou WS, Turng BF, Minah GE, Coll JA. Inhibition of pure cultures of oral bacteria by root canal filling materials. Pediatr Dent 18: 444-9, 1996.
70. Tchaou WS Turng BF Minah GE Coll JA. In vitro inhibition of bacteria from root canals of primary teeth by various dental materials. Pediatr Dent 17: 351-5, 1995.
71. Lewis BB. Formaldehyde in dentistry: a review of mutagenic and carcinogenic potential. JADA 103: 429-34, 1981.